PharmaPhorum: Viva in vivo – The next generation of cell therapy is fast approaching

by rob@robmaguiredesigns.com | Oct 28, 2024 | News

BioPharma: Astellas teams up with startup Kelonia to make ‘in vivo’ cell therapies

by rob@robmaguiredesigns.com | Feb 21, 2024 | News

GEN Edge: Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies

by rob@robmaguiredesigns.com | Feb 21, 2024 | News

Endpoint News: Astellas pursues ‘convertible’ in vivo CAR-T cell therapies with Kelonia Therapeutics

by rob@robmaguiredesigns.com | Feb 16, 2024 | News

Fierce Biotech: Astellas-owned Xyphos offers more than $800M for Kelonia’s in vivo delivery know-how

by rob@robmaguiredesigns.com | Feb 15, 2024 | News

Myeloma Research: Gene therapy targeting T-cells shows promise in myeloma animal models

by rob@robmaguiredesigns.com | Jul 7, 2023 | News